Working… Menu

A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p Deletion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01889186
Recruitment Status : Completed
First Posted : June 28, 2013
Last Update Posted : November 27, 2020
Genentech, Inc.
Information provided by (Responsible Party):

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : October 28, 2020
Actual Study Completion Date : October 28, 2020
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 October 6, 2021
November 4, 2021
2 November 19, 2021
Publications automatically indexed to this study by Identifier (NCT Number):